Paige M. Fox, Ph.D.
Affiliations: | 2006 | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Microbiology Biology, Molecular BiologyGoogle:
"Paige Fox"Parents
Sign in to add mentor| Gordon L. Archer | grad student | 2006 | VCU | |
| (Characterization of vancomycin resistance in Staphylococcus aureus.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Min JG, Sanchez Rangel UJ, Franklin A, et al. (2020) Topical Antibiotic Elution in a Collagen-Rich Hydrogel is Successful for Inhibiting Bacterial Growth and Biofilm Formation in Vitro. Antimicrobial Agents and Chemotherapy |
| Noto MJ, Fox PM, Archer GL. (2008) Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 52: 1221-9 |
| Fox PM, Climo MW, Archer GL. (2007) Lack of relationship between purine biosynthesis and vancomycin resistance in Staphylococcus aureus: a cautionary tale for microarray interpretation. Antimicrobial Agents and Chemotherapy. 51: 1274-80 |
| Nelson JL, Rice KC, Slater SR, et al. (2007) Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysis. Antimicrobial Agents and Chemotherapy. 51: 616-22 |
| Fox PM, Lampen RJ, Stumpf KS, et al. (2006) Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 50: 2951-6 |